#viremia — RNews

Top 1d 2d 3d 7d 14d 30d

Show 10 20 50

hot top new

Oct 05 Oct 06 Oct 07 Oct 08 Oct 09 Oct 10 Oct 11

#viremia — top 20, last 30d

1

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India. (linkinghub.elsevier.com)

Goel A … Aggarwal R The Lancet 2026-09-30

#hepatitis c #clinical trial #antiviral #treatment #viremia